Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.81 -0.05 (-0.62%)
As of: Oct 23, 2026 · 3:58 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Cash from Financing Activities (2021 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded Cash from Financing Activities of $8.43 million in Q2 2026, up 6.8% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Cash from Financing Activities (2021 - 2026) Analysis & Trends

On a TTM basis, Aspire Biopharma Holdings' Cash from Financing Activities came in at $19.15 million as of Jun 30, 2026, up 518.7% year-over-year; for FY2025, it came in at $5.92 million.

  • Annual Cash from Financing Activities has a four-year compound annual growth rate of 123.2% (FY2021 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $257,645 in FY2024, -$284.76 million in FY2023, $296.59 million in FY2022 and $238,596 in FY2021.
  • The Q2 2026 figure is the highest quarterly Cash from Financing Activities since Q1 2022.
  • Per Business Quant, the preceding three quarters came in at $7.89 million (Q1 2026), -$16,526 (Q4 2025) and $2.85 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.43 Mn
Mar 31, 2026 7.89 Mn
Dec 31, 2025 -16,526.00
Sep 30, 2025 2.85 Mn
Mar 31, 2025 3.09 Mn
Dec 31, 2024 -492,477.00
Sep 30, 2024 492,477.00
Jun 30, 2024 28,561.00
Mar 31, 2024 229,084.00
Dec 31, 2023 155,848.00
Sep 30, 2023 -632,968.00
Mar 31, 2022 296.59 Mn
Dec 31, 2021 25,870.00
Sep 30, 2021 181,811.00
API Access

Aspire Biopharma Holdings, Inc. Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ASBP&period=max&api_key=YOUR_API_KEY